Treatment options in the modern management of Parkinson disease.
Schapira
Anthony H V
AH
University Department of Clinical Neurosciences, Institute of Neurology, University College London, England. a.schapira@medsch.ucl.ac.uk
D018450:Disease Progression; D015259:Dopamine Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D009069:Movement Disorders / Q000517:prevention & control; D019636:Neurodegenerative Diseases / Q000150:complications / Q000209:etiology; D009462:Neurology / Q000639:trends*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
D015259:Dopamine Agents